{"content":"<li class=\"n-box-item date-title\" data-end=\"1495684799\" data-start=\"1495598400\" data-txt=\"Monday, December 23, 2019\">Wednesday, May 24, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3269747\" data-ts=\"1495666737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFO\" target=\"_blank\">INFO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269747-ihs-markit-to-join-s-and-p-500-replacing-tegna\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IHS Markit to join S&amp;P 500, replacing TEGNA</a></h4><ul>     <li>IHS&nbsp;Markit (NASDAQ:<a href='https://seekingalpha.com/symbol/INFO' title='IHS Markit Ltd.'>INFO</a>) <font color='green'>+4.3%</font>&nbsp;AH on news it is <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/530961_info5tgnacars4jcptime6.pdf?force_download=true\" target=\"_blank\">joining the S&amp;P 500</a>, replacing TEGNA (NYSE:<a href='https://seekingalpha.com/symbol/TGNA' title='TEGNA'>TGNA</a>), effective prior to the open on June 2; TGNA is spinning off Cars.com and both companies will drop to the S&amp;P&nbsp;MidCap 400, replacing J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) and Time Inc. (TIME).</li>     <li>Yahoo (YHOO) will drop out of the S&amp;P 500 effective at the open on June 19, with a replacement candidate to be named later.</li><li>Independence Realty Trust (NYSEMKT:<a href='https://seekingalpha.com/symbol/IRT' title='Independence Realty Trust'>IRT</a>) +2% AH, as it will replace Ultratech (NASDAQ:<a href='https://seekingalpha.com/symbol/UTEK' title='Ultratech, Inc.'>UTEK</a>), which is being acquired by Veeco Instruments,  in the S&amp;P SmallCap 600, effective prior to the open on May  30; JCP and TIME will bump Tuesday Morning (NASDAQ:<a href='https://seekingalpha.com/symbol/TUES' title='Tuesday Morning Corp.'>TUES</a>) and Hornbeck Offshore Services (NYSE:<a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a>) from the index.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269747\" data-linked=\"IHS Markit to join S&amp;P 500, replacing TEGNA\" data-tweet=\"$INFO $INFO $TGNA - IHS Markit to join S&amp;P 500, replacing TEGNA https://seekingalpha.com/news/3269747-ihs-markit-to-join-s-and-p-500-replacing-tegna?source=tweet\" data-url=\"https://seekingalpha.com/news/3269747-ihs-markit-to-join-s-and-p-500-replacing-tegna\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269746\" data-ts=\"1495666639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEL\" target=\"_blank\">CEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269746-cellcomminus-4_1-revenues-profits-show-fall-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellcom -4.1% as revenues, profits show fall-off</a></h4><ul>   <li>Cellcom Israel (NYSE:<a href='https://seekingalpha.com/symbol/CEL' title='Cellcom Israel, Ltd.'>CEL</a>) <font color='red'>fell 4.1%</font> after its <a href=\"https://seekingalpha.com/news/3269459-cellcom-israel-reports-q1-results\" target=\"_blank\">Q1 earnings</a> showed revenues dropping and operating and net income falling harder.</li>    <li>In cellular service, subscribers dipped 0.7% Y/Y to 2.79M. Churn rate rose 0.9 points to 12%, and monthly ARPU fell 7.7% to 60.2 shekels.</li>    <li>In its fixed-line unit, Internet infrastructure households rose 43% to 173,000; TV households increased 65.3% to 124,000.</li>    <li>Revenue breakout: Cellular, 692M shekels (down 11.1%; service, 509M shekels, down 8.9%, and equipment, 183M shekels, down 16.4%); fixed-line, 316M shekels (up 7.8%; service, 279M shekels, up 5.7%, and equipment, 37M shekels, up 27.6%).</li>    <li><a href=\"https://seekingalpha.com/pr/16842231-cellcom-israel-announces-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3269746\" data-linked=\"Cellcom -4.1% as revenues, profits show fall-off\" data-tweet=\"$CEL - Cellcom -4.1% as revenues, profits show fall-off https://seekingalpha.com/news/3269746-cellcomminus-4_1-revenues-profits-show-fall-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3269746-cellcomminus-4_1-revenues-profits-show-fall-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269738\" data-ts=\"1495662330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269738-guessplus-15-on-smaller-expected-q1-loss-revenue-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess? +15% on smaller than expected Q1 loss, revenue beat</a></h4><ul>     <li>Guess?&nbsp;(NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a>)&nbsp;<font color='green'>+15.7</font>%&nbsp;AH after posting a narrower than expected <a href=\"https://seekingalpha.com/news/3269702-guess-beats-0_08-beats-revenue\" target=\"_blank\">Q1 loss</a> and better than expected revenues, while issuing improved 2018 guidance.</li><li>GES says Q1 same-store sales for the Americas, including e-commerce, fell 15% Y/Y, but the result is better than the 16.4% analyst consensus estimate; same-store sales rose 5% in Europe and 4% in Asia.</li><li>GES issues downside guidance for Q2, seeing EPS of $0.08-$0.11 vs. $0.12 analyst consensus estimate on net revenue growth of 2%-4%, but forecasts better than expected FY 2018 EPS of $0.34-$0.44 vs. $0.33 consensus on net revenue growth of 3.5%-5%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269738\" data-linked=\"Guess? +15% on smaller than expected Q1 loss, revenue beat\" data-tweet=\"$GES - Guess? +15% on smaller than expected Q1 loss, revenue beat https://seekingalpha.com/news/3269738-guessplus-15-on-smaller-expected-q1-loss-revenue-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3269738-guessplus-15-on-smaller-expected-q1-loss-revenue-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269731\" data-ts=\"1495661722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269731-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a> <font color='green'>+24.6%</font>. <a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a> <font color='green'>+14.7%</font>. <a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+13.7%</font>. <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines'>FSM</a> <font color='green'>+12.6%</font>. <a href='https://seekingalpha.com/symbol/WSM' title='Williams-Sonoma Inc.'>WSM</a> <font color='green'>+8.1%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-19.2%</font>. <a href='https://seekingalpha.com/symbol/CMRE' title='Costamare Inc.'>CMRE</a> <font color='red'>-9.2%</font>. OZRK <font color='red'>-5.0%</font>. <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-2.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269731\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AERI $PSTG $GES - After Hours Gainers / Losers https://seekingalpha.com/news/3269731-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3269731-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269718\" data-ts=\"1495659263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMRE\" target=\"_blank\">CMRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269718-costamare-to-launch-12_5m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costamare to launch 12.5M-share offering</a></h4><ul><li>Costamare (NYSE:<a href='https://seekingalpha.com/symbol/CMRE' title='Costamare Inc.'>CMRE</a>) <font color='red'>-5.8%</font> AH after announcing a <a href=\"https://seekingalpha.com/pr/16843441-costamare-inc-announces-public-offering-common-stock\" target=\"_blank\">public offering</a> of 12.5M common shares, with an underwriters option to purchase up to an additional 1.875M shares.</li><li>CMRE says the Konstantakopoulos family, who in the aggregate own a majority of its  shares, intend to purchase ~$10 M of shares in the offering.</li><li>CMRE says it plans to use the proceeds for capital   spending, including vessel acquisitions, and for other general  corporate  purposes, which may include paying down debt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269718\" data-linked=\"Costamare to launch 12.5M-share offering\" data-tweet=\"$CMRE - Costamare to launch 12.5M-share offering https://seekingalpha.com/news/3269718-costamare-to-launch-12_5m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3269718-costamare-to-launch-12_5m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269713\" data-ts=\"1495659068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269713-hpplus-3_6-on-q2-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP +3.6% on Q2 beats</a></h4><ul>     <li>HP Inc (<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a> <font color='green'>+0.2%</font>) Q2 2017 results<strong>:</strong> revenue $12.4B (+7.0% Y/Y,&nbsp;beats by $520M), EPS $0.40 (beats by $0.01), cash provided by operating activities $0.5B, repurchases and dividends $447M.</li>     <li>Segment sales<b>:</b> Personal Systems +10% Y/Y -- Commercial +7%, Consumer +16%; total units +5% (Notebooks +12% and Desktops -6%). Printing +2%; with total hardware units +4% (Commercial hardware +6% and Consumer hardware +3%).</li>     <li>Q3 guidance: EPS $0.40 - $0.43 ($0.42 consensus).</li>     <li>FY2017 guidance: raised to $1.59 - $1.66 ($1.62 consensus).</li>     <li>Shares are&nbsp;<font color='green'>3.6% higher</font>&nbsp;aftermarket.</li>     <li><a href=\"https://seekingalpha.com/pr/16843364\" target=\"_blank\">Press release</a> / <a href=\"http://www.hp.com/investor/2017Q2Webcast\" target=\"_blank\">Conference call</a> / <a href=\"https://seekingalpha.com/filing/3565876\" target=\"_blank\">8-K</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3269713\" data-linked=\"HP +3.6% on Q2 beats\" data-tweet=\"$HPQ - HP +3.6% on Q2 beats https://seekingalpha.com/news/3269713-hpplus-3_6-on-q2-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3269713-hpplus-3_6-on-q2-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269712\" data-ts=\"1495658342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDUS\" target=\"_blank\">RDUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269712-late-stage-extension-study-confirms-long-term-treatment-effect-of-radius-healths-tymlos\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Late-stage extension study confirms long-term treatment effect of Radius Health&#39;s TYMLOS; shares up 3% after hours</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16843341-radius-announces-positive-top-line-results-completed-activextend-study-tymlos-postmenopausal\" target=\"_blank\">Results </a>from a 24-month extension study showed the sustained treatment benefit of Radius Health's (NASDAQ:<a href='https://seekingalpha.com/symbol/RDUS' title='Radius Health, Inc.'>RDUS</a>) TYMLOS (abaloparatide) in reducing the risk of fractures in postmenopausal women. The trial, ACTIVExtend, met all of its primary and secondary endpoints.</li><li>ACTIVExtend enrolled patients who receive TYMLOS for 18 months who were transitioned to receive 24 additional months of alendronate (Merck's Fosamax).</li><li>At month 43, TYMLOS-treated patients experienced an 84% relative risk reduction in risk of new vertebral fractures compared to those who received placebo before entering the extension study.</li><li>Shares are up<font color='green'> 3%</font>&nbsp;after hours on average volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3261375-fda-oks-radius-healths-osteoporosis-med-tymlos-shares-11-percent\" target=\"_blank\">FDA OKs Radius Health's osteoporosis med TYMLOS; shares up 11%</a> (April 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3269712\" data-linked=\"Late-stage extension study confirms long-term treatment effect of Radius Health&#39;s TYMLOS; shares up 3% after hours\" data-tweet=\"$RDUS - Late-stage extension study confirms long-term treatment effect of Radius Health&#39;s TYMLOS; shares up 3% after hours https://seekingalpha.com/news/3269712-late-stage-extension-study-confirms-long-term-treatment-effect-of-radius-healths-tymlos?source=tweet\" data-url=\"https://seekingalpha.com/news/3269712-late-stage-extension-study-confirms-long-term-treatment-effect-of-radius-healths-tymlos\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269701\" data-ts=\"1495657631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTAP\" target=\"_blank\">NTAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269701-netapp-down-3_4-on-q4-beat-weak-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetApp down 3.4% on Q4 beat with weak guidance</a></h4><ul>     <li>NetApp (<a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a> <font color='green'>+0.2%</font>) Q4 2017 results: revenue $1.48B (+7.2% Y/Y,&nbsp;beats by $40M), EPS $0.86 (beats by $0.04), net income $239M (+52% Y/Y), cash, cash equivalents and investments $4.9B, cash from operations $365 million.</li>     <li>Dividend increase: Dividend will increase 5% to $0.20 per share in Q1.</li>     <li>Q1 2018 projections: revenue $1.24B-$1.39B ($1.33B consensus), EPS $0.49-$0.57 ($0.67 consensus).</li>     <li>Shares are <font color='red'>3.4% lower</font> after hours.</li>     <li><a href=\"https://seekingalpha.com/pr/16843356-netapp-reports-fourth-quarter-fiscal-year-2017-results\" target=\"_blank\">Press release</a> / <a href=\"http://investors.netapp.com/\" target=\"_blank\">Conference call</a> / <a href=\"https://seekingalpha.com/filing/3565798\" target=\"_blank\">8-K</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3269701\" data-linked=\"NetApp down 3.4% on Q4 beat with weak guidance\" data-tweet=\"$NTAP - NetApp down 3.4% on Q4 beat with weak guidance https://seekingalpha.com/news/3269701-netapp-down-3_4-on-q4-beat-weak-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3269701-netapp-down-3_4-on-q4-beat-weak-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269705\" data-ts=\"1495657495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OZK\" target=\"_blank\">OZK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269705-bank-of-ozarks-raising-capital-shares-down-1_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of the Ozarks raising capital; shares down 1.8%</a></h4><ul><li>The offering size <a href=\"https://seekingalpha.com/pr/16843390-bank-ozarks-inc-announces-public-offering-common-stock\" target=\"_blank\">is 6.6M shares</a>, and the underwriter (JPMorgan) has a greenshoe option to buy another 990K shares.</li><li>OZRK<font color='red'> -1.8%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3269705\" data-linked=\"Bank of the Ozarks raising capital; shares down 1.8%\" data-tweet=\"$OZK - Bank of the Ozarks raising capital; shares down 1.8% https://seekingalpha.com/news/3269705-bank-of-ozarks-raising-capital-shares-down-1_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3269705-bank-of-ozarks-raising-capital-shares-down-1_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269704\" data-ts=\"1495657421\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AERI\" target=\"_blank\">AERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269704-aeris-roclatan-successful-in-late-stage-study-of-eye-drop-roclatan-shares-up-28-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeri&#39;s Roclatan successful in late-stage study of eye drop Roclatan; shares up 28% after hours</a></h4><ul><li>Aerie Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a>) jumps&nbsp;<font color='green'>28%</font>&nbsp;after hours on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16843349-aerie-pharmaceuticals-reports-positive-roclatan-netarsudil-latanoprost-ophthalmic-solution\" target=\"_blank\">announcement </a>of positive results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02674854?term=aerie+pharmaceuticals&amp;phase=2&amp;rank=3\" target=\"_blank\">Phase 3 clinical trial</a>, Mercury 2, comparing the efficacy of Roclatan against each of its components, netarsudil and latanoprost, in lowering intraocular pressure &#40;IOP&#41; in patients with open-angle glaucoma or ocular hypertension.</li><li>Roclatan lowered IOP 1 - 3 mmHg more than monotherapy with either component.</li><li>A third Phase 3 registration study, Mercury 3, will commence in Europe mid-year. The company expects to file its U.S. marketing application in H1 2018.</li><li>Management will host a conference call today at 5:00 pm ET to discuss the data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269704\" data-linked=\"Aeri&#39;s Roclatan successful in late-stage study of eye drop Roclatan; shares up 28% after hours\" data-tweet=\"$AERI - Aeri&#39;s Roclatan successful in late-stage study of eye drop Roclatan; shares up 28% after hours https://seekingalpha.com/news/3269704-aeris-roclatan-successful-in-late-stage-study-of-eye-drop-roclatan-shares-up-28-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3269704-aeris-roclatan-successful-in-late-stage-study-of-eye-drop-roclatan-shares-up-28-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269702\" data-ts=\"1495657190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269702-guess-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess beats by $0.08, beats on revenue</a></h4><ul><li>Guess (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a>): Q1 EPS of -$0.24 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $458.58M (+2.2% Y/Y) <font color='green'>beats by $9.36M</font>.</li><li>Shares <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/pr/16843432-guess-inc-reports-first-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269702\" data-linked=\"Guess beats by $0.08, beats on revenue\" data-tweet=\"$GES - Guess beats by $0.08, beats on revenue https://seekingalpha.com/news/3269702-guess-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3269702-guess-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269700\" data-ts=\"1495657122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSM\" target=\"_blank\">WSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269700-williams-sonoma-beats-0_02-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Williams-Sonoma beats by $0.02,  revenue in-line</a></h4><ul><li>Williams-Sonoma (NYSE:<a href='https://seekingalpha.com/symbol/WSM' title='Williams-Sonoma Inc.'>WSM</a>): Q1 EPS of $0.51 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $1.11B (+0.9% Y/Y) in-line.</li><li>Shares <font color='green'>+8.7%</font>.</li><li><a href='https://seekingalpha.com/pr/16843431-williams-sonoma-inc-announces-first-quarter-2017-results-net-revenues-grow-1_2-percent'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269700\" data-linked=\"Williams-Sonoma beats by $0.02,  revenue in-line\" data-tweet=\"$WSM - Williams-Sonoma beats by $0.02, revenue in-line https://seekingalpha.com/news/3269700-williams-sonoma-beats-0_02-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3269700-williams-sonoma-beats-0_02-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269699\" data-ts=\"1495657108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269699-yield-curve-flattens-on-prospect-of-june-rate-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yield curve flattens on prospect of June rate hike</a></h4><ul><li>The <a href=\"https://seekingalpha.com/news/3269659-dollar-dips-fomc-minutes-show-rate-hike-soon\" target=\"_blank\">minutes from the FOMC's </a>May 2-3 meeting left little doubt of the central bank's intention to hike again at the June get-together.</li><li><a href=\"http://www.cmegroup.com/trading/interest-rates/stir/30-day-federal-fund.html\" target=\"_blank\">July short-term interest rate futures </a>continue to price in more than an 80% chance of a move; futures are discounting only about 60% odds of a rate hike beyond June.</li><li>The 10-year Treasury yield fell nearly four basis points following the release of the minutes, now yielding close to the year's low at 2.246%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.55%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-1%</font></li><li>Banks are fans of higher rates, but not necessarily of a flatter curve - they underperformed the market today, with <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a><font color='red'> -0.6%</font>&nbsp;and <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a>&nbsp;<font color='red'>-0.35%</font>&nbsp;vs. the S&amp;P 500's<font color='green'> 0.25% advance</font>. The broader financial sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>) was flat on the session.</li><li>Yield curve ETFs: <a href='https://seekingalpha.com/symbol/STPP' title='iPath U.S. Treasury Steepener ETN'>STPP</a>, <a href='https://seekingalpha.com/symbol/FLAT' title='iPath U.S. Treasury Flattener ETN'>FLAT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269699\" data-linked=\"Yield curve flattens on prospect of June rate hike\" data-tweet=\"$TLT $TBT $KRE - Yield curve flattens on prospect of June rate hike https://seekingalpha.com/news/3269699-yield-curve-flattens-on-prospect-of-june-rate-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3269699-yield-curve-flattens-on-prospect-of-june-rate-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269698\" data-ts=\"1495657082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVH\" target=\"_blank\">PVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269698-phillips-van-heusen-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phillips-Van Heusen beats by $0.05, beats on revenue</a></h4><ul><li>Phillips-Van Heusen (NYSE:<a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a>): Q1 EPS of $1.65 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $1.99B (+3.6% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+4.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16843437-pvh-corp-reports-2017-first-quarter-revenue-eps-guidance-raises-full-year-guidance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269698\" data-linked=\"Phillips-Van Heusen beats by $0.05, beats on revenue\" data-tweet=\"$PVH - Phillips-Van Heusen beats by $0.05, beats on revenue https://seekingalpha.com/news/3269698-phillips-van-heusen-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3269698-phillips-van-heusen-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269697\" data-ts=\"1495657006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSRA\" target=\"_blank\">CSRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269697-csra-beats-0_05-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CSRA beats by $0.05,  revenue in-line</a></h4><ul><li>CSRA (NYSE:<a href='https://seekingalpha.com/symbol/CSRA' title='CSRA Inc.'>CSRA</a>): Q4 EPS of $0.49 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $1.25B (-3.1% Y/Y) in-line.</li><li>Shares <font color='green'>+2%</font>.</li><li><a href='https://seekingalpha.com/pr/16843427-csra-announces-fourth-quarter-fiscal-year-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269697\" data-linked=\"CSRA beats by $0.05,  revenue in-line\" data-tweet=\"$CSRA - CSRA beats by $0.05, revenue in-line https://seekingalpha.com/news/3269697-csra-beats-0_05-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3269697-csra-beats-0_05-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269682\" data-ts=\"1495656342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTG\" target=\"_blank\">PSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269682-pure-storage-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pure Storage beats by $0.08, beats on revenue</a></h4><ul><li>Pure Storage (NYSE:<a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a>): Q1 EPS of -$0.14 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $182.6M (+30.5% Y/Y) <font color='green'>beats by $5.07M</font>.</li><li>Shares <font color='green'>+3.4%</font>.</li><li><a href='https://seekingalpha.com/pr/16843360-pure-storage-announces-first-quarter-fiscal-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269682\" data-linked=\"Pure Storage beats by $0.08, beats on revenue\" data-tweet=\"$PSTG - Pure Storage beats by $0.08, beats on revenue https://seekingalpha.com/news/3269682-pure-storage-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3269682-pure-storage-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269753\" data-ts=\"1495654790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BG\" target=\"_blank\">BG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269753-bunge-hits-52-week-highs-consolidation-talk-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bunge hits 52-week highs as consolidation talk continues</a></h4><ul>     <li>Bunge (<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='green'>+1%</font>) surges to 52-week highs even after the company <a href=\"https://seekingalpha.com/news/3269547-bunge-says-talks-glencore-minus-7-percent-premarket\" target=\"_blank\">tamped down speculation</a> of some kind of business combination, as investors nevertheless remain convinced that <a href=\"http://www.reuters.com/article/us-bunge-stocks-idUSKBN18K2BP\" target=\"_blank\">merger deals are ahead</a> for large grain traders including BG and Glencore (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>).</li>     <li>J.P. Morgan's Ann Duignan says she is surprised that BG struck a \"relatively dismissive tone\" on the Glencore deal, as its \"core businesses remain under pressure, with agribusiness margins weighed down by burdensome supplies of crops in all producer regions.\"</li>     <li>Credit Suisse's Robert Moskow believes CEO Soren Schroder and the board <a href=\"https://thefly.com/landingPageNews.php?id=2557364&amp;headline=BG;GLNCY-Bunge-CEO-board-likely-to-engage-Glencore-says-Credit-Suisse\" target=\"_blank\">will engage with Glencore</a>, as a tie-up seems like a logical way to address the glut of grain supplies and the persistent problem of slow farmer-selling,  and noting that Schroder himself has said that the industry needs to consolidate in order to improve returns.</li>     <li>BG could sell for a 10x multiple, which would imply a transaction value of ~$90/share, says Morningstar analyst Seth Goldstein.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269753\" data-linked=\"Bunge hits 52-week highs as consolidation talk continues\" data-tweet=\"$BG $BG $GLCNF - Bunge hits 52-week highs as consolidation talk continues https://seekingalpha.com/news/3269753-bunge-hits-52-week-highs-consolidation-talk-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3269753-bunge-hits-52-week-highs-consolidation-talk-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269671\" data-ts=\"1495653453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXAS\" target=\"_blank\">AXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269671-abraxas-petroleum-buys-permian-basin-acreage-in-22_2m-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abraxas Petroleum buys Permian Basin acreage in $22.2M deal</a></h4><ul>     <li>Abraxas Petroleum (<a href='https://seekingalpha.com/symbol/AXAS' title='Abraxas Petroleum Corporation'>AXAS</a> <font color='green'>+4.3%</font>) after <a href=\"https://seekingalpha.com/pr/16842000-abraxas-announces-acquisition-2008-net-wolfcamp-bone-spring-acres\" target=\"_blank\">agreeing to acquire</a> minerals rights in Texas's Bone Spring and Wolfcamp formations from an unnamed buyer for $22.2M.</li>     <li>AXAS says the ~2K acres of oil leases are spread out across seven units that are immediately adjacent or near its existing leases in Ward County, Tex.</li><li>AXAS says it plans to fund the deal entirely through its existing line of credit, and its $110M capital budget for 2017 remains unchanged.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269671\" data-linked=\"Abraxas Petroleum buys Permian Basin acreage in $22.2M deal\" data-tweet=\"$AXAS - Abraxas Petroleum buys Permian Basin acreage in $22.2M deal https://seekingalpha.com/news/3269671-abraxas-petroleum-buys-permian-basin-acreage-in-22_2m-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3269671-abraxas-petroleum-buys-permian-basin-acreage-in-22_2m-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269668\" data-ts=\"1495652404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269668-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> COOL <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/DMRC' title='Digimarc Corporation'>DMRC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SMTX' title='SMTC Corporation'>SMTX</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OOMA' title='Ooma'>OOMA</a> <font color='red'>-28%</font>. SONS <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/DGII' title='Digi International Inc.'>DGII</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269668\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$PTE $IDN $PTI - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3269668-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3269668-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269666\" data-ts=\"1495652045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269666-arcelormittal-agrees-to-concessions-on-delayed-897m-india-joint-venture\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal agrees to concessions on delayed $897M India joint venture</a></h4><ul>     <li>ArcelorMittal (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-2.6%</font>) <a href=\"http://www.reuters.com/article/us-india-arcelormittal-sail-idUSKBN18K17G\" target=\"_blank\">agrees to make concessions</a> to Steel Authority of India to seal a delayed $897M automotive joint venture.</li>     <li>The two companies are close to ironing out key commercial terms to close the deal, including non-compete and exit clauses as well as finalizing policy on arbitration, Reuters reports.</li>     <li>MT has been trying for nearly a decade to gain a foothold in India, which is the only major steel market where demand is rising fast and government policy is increasingly favoring locally made products.</li>     <li>MT may follow up the JV deal with a larger presence through the purchase of a stake in three of SAIL's weak units, according to the report.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269666\" data-linked=\"ArcelorMittal agrees to concessions on delayed $897M India joint venture\" data-tweet=\"$MT - ArcelorMittal agrees to concessions on delayed $897M India joint venture https://seekingalpha.com/news/3269666-arcelormittal-agrees-to-concessions-on-delayed-897m-india-joint-venture?source=tweet\" data-url=\"https://seekingalpha.com/news/3269666-arcelormittal-agrees-to-concessions-on-delayed-897m-india-joint-venture\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269665\" data-ts=\"1495652006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269665-upgrades-flow-in-after-positive-ad-comm-vote-on-pumas-neratinib\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upgrades flow in after positive Ad Comm vote on Puma&#39;s neratinib</a></h4><ul><li>Predictably, sell-side analysts are quick to ratchet up their views on Puma Biotechnology (<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='green'>+25.2%</font>) after today's positive advisory committee vote on breast cancer drug neratinib.</li><li>Stifel: reiterates Buy rating and price target raised to $105 (47% upside) from $88.</li><li>BofA/Merrill Lynch: Buy rating and price target raised to $86 (20% upside) from $72.</li><li>JPMorgan: Overweight with $89 price target.</li><li>CSFB: Outperform with $58 (needs updating) price target.</li><li>Credit Suisse: Buy with $58 (also needs updating) price target.</li><li>Citigroup: Buy rating and $88 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269665\" data-linked=\"Upgrades flow in after positive Ad Comm vote on Puma&#39;s neratinib\" data-tweet=\"$PBYI - Upgrades flow in after positive Ad Comm vote on Puma&#39;s neratinib https://seekingalpha.com/news/3269665-upgrades-flow-in-after-positive-ad-comm-vote-on-pumas-neratinib?source=tweet\" data-url=\"https://seekingalpha.com/news/3269665-upgrades-flow-in-after-positive-ad-comm-vote-on-pumas-neratinib\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269664\" data-ts=\"1495651614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269664-trade-deskminus-2_8-on-pricing-4_32m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Trade Desk -2.8% on pricing 4.32M-share offering</a></h4><ul>   <li>The Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a>) is <font color='red'>off 2.8%</font> after a late-night pricing of an upsized <a href=\"https://seekingalpha.com/news/3269301-trade-desk-follow-will-sell-3_33m-shares\" target=\"_blank\">follow-on offering</a> of a little over 4.316M shares.</li>    <li>The company set the offering (shares sold by certain stockholders) <a href=\"https://seekingalpha.com/pr/16842200-trade-desk-prices-follow-offering\" target=\"_blank\">at $52/share</a>. The stock closed at $53.48 yesterday, and is down to $51.98 today.</li>    <li>The selling stockholders granted a 30-day option to buy up to an additional 647,467 shares in the offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269664\" data-linked=\"The Trade Desk -2.8% on pricing 4.32M-share offering\" data-tweet=\"$TTD - The Trade Desk -2.8% on pricing 4.32M-share offering https://seekingalpha.com/news/3269664-trade-deskminus-2_8-on-pricing-4_32m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3269664-trade-deskminus-2_8-on-pricing-4_32m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269658\" data-ts=\"1495649802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269658-geminus-2-immelt-says-2018-earnings-target-be-high-end-of-range\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE -2% as Immelt says 2018 earnings target would be at &quot;high end&quot; of range</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-1.8%</font>) sinks near 52-week lows after CEO&nbsp;Jeffrey Immelt says the company will have to <a href=\"https://www.bloomberg.com/news/articles/2017-05-24/ge-drops-as-immelt-sees-challenges-to-achieving-2018-targets\" target=\"_blank\">stretch to meet a goal of earning $2/share in 2018</a> as it contends with a difficult oil market and headwinds in equipment pricing.</li>     <li>In a <a href=\"http://www.gereports.com/immelt-updates-investors-ges-digital-industrial-strategy/\" target=\"_blank\">presentation</a> at an investor conference, Immelt reassures investors that GE&rsquo;s cash position remains strong, its dividend is a priority and it remains committed to 2018 goals, but says the $2 target would be at the high end of expectations, given current market conditions.</li>     <li>The stock turned from green to red as Immelt gave his presentation and has stayed there; GE shares, which have attracted activist investor Trian Fund Management, have tumbled 12%&nbsp;YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269658\" data-linked=\"GE -2% as Immelt says 2018 earnings target would be at &quot;high end&quot; of range\" data-tweet=\"$GE - GE -2% as Immelt says 2018 earnings target would be at &quot;high end&quot; of range https://seekingalpha.com/news/3269658-geminus-2-immelt-says-2018-earnings-target-be-high-end-of-range?source=tweet\" data-url=\"https://seekingalpha.com/news/3269658-geminus-2-immelt-says-2018-earnings-target-be-high-end-of-range\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269656\" data-ts=\"1495648847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269656-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>    <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/WPT' title='World Point Terminals, LP'>WPT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AXAS' title='Abraxas Petroleum Corporation'>AXAS</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='red'>-34%</font>. <a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a> <font color='red'>-34%</font>. <a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines'>FSM</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269656\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$TRNX $FSI $ERN - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3269656-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3269656-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269653\" data-ts=\"1495648585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269653-puma-biotechplus-29-after-fda-committee-approves-breast-cancer-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Puma Biotech +29% after FDA committee approves breast cancer drug</a></h4><ul>   <li>Puma Biotechnology (NYSE:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) has resumed trading <font color='green'>up 29.4%</font> after word of an FDA advisory committee's <a href=\"https://seekingalpha.com/news/3269622-trading-puma-bio-halted-pending-ad-comm-vote-neratinib\" target=\"_blank\">12-4 approval</a> of its experimental breast cancer drug.</li>    <li>Neratinib's benefits outweigh its risks, the panel concluded, reducing the risk of disease recurrence, even while noting <a href=\"https://www.reuters.com/article/us-puma-biotec-cancer-idUSKBN18K29X\" target=\"_blank\">it's a modest benefit</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269653\" data-linked=\"Puma Biotech +29% after FDA committee approves breast cancer drug\" data-tweet=\"$PBYI - Puma Biotech +29% after FDA committee approves breast cancer drug https://seekingalpha.com/news/3269653-puma-biotechplus-29-after-fda-committee-approves-breast-cancer-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3269653-puma-biotechplus-29-after-fda-committee-approves-breast-cancer-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269647\" data-ts=\"1495646859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269647-bidding-war-expected-for-abercrombie-fitch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bidding war expected for Abercrombie &amp; Fitch</a></h4><ul> <li>Abercrombie &amp; Fitch (NYSE:<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a>) is seeing <a href=\"https://www.wsj.com/articles/cerburus-american-eagle-work-on-joint-bid-for-abercrombie-fitch-1495645290\" target=\"_blank\">takeover interest</a> from buyout firms, Express (<a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='green'>+0.4%</font>) and a pairing of Cerberus Capital American Eaglefitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+3%</font>), sources tell The Wall Street Journal.</li> <li>There's some speculation that the Cerberus-AEO bid could end up being the most attractive of the bunch due to the deep pockert of Cerberus and potential synergies with American Eagle.</li> <li>Shares of A&amp;F are <font color='green'>up 5.66%</font> after coming off a trading halt. Th stock has moved up 24% since its lowest level in April as some M&amp;A potential has been baked in slowly.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3269645-abercrombie-and-fitch-spikes-takeover-report\" target=\"_blank\">Abercrombie &amp; Fitch spikes after takeover report</a> (May 24)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269647\" data-linked=\"Bidding war expected for Abercrombie &amp; Fitch\" data-tweet=\"$ANF $ANF $EXPR - Bidding war expected for Abercrombie &amp; Fitch https://seekingalpha.com/news/3269647-bidding-war-expected-for-abercrombie-fitch?source=tweet\" data-url=\"https://seekingalpha.com/news/3269647-bidding-war-expected-for-abercrombie-fitch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269646\" data-ts=\"1495645848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269646-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AAMC' title='Altisource Asset Management Corp'>AAMC</a> <font color='green'>+9%</font>. FGL <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/MARPS' title='Marine Petroleum Trust'>MARPS</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/AIII' title='ACRE Realty Investors Inc.'>AIII</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269646\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$AAMC $FG $WHLR - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3269646-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3269646-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269645\" data-ts=\"1495645602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269645-abercrombie-fitch-spikes-after-takeover-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp; Fitch spikes after takeover report</a></h4><ul> <li>Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='green'>+8.8%</font>) spikes after the Wall Street Journal reports that Cerberus and American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+2.5%</font>) are planning to make a bid for the retailer.</li> <li>The story is still developing.</li> <li>Shares of A&amp;F are currently in trading halt.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3269645\" data-linked=\"Abercrombie &amp; Fitch spikes after takeover report\" data-tweet=\"$ANF $ANF $AEO - Abercrombie &amp; Fitch spikes after takeover report https://seekingalpha.com/news/3269645-abercrombie-fitch-spikes-after-takeover-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3269645-abercrombie-fitch-spikes-after-takeover-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269644\" data-ts=\"1495645186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGI\" target=\"_blank\">TGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269644-triumphplus-27-on-strong-earnings-bombardier-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Triumph +27% on strong earnings, Bombardier settlement</a></h4><ul>     <li>Aircraft parts supplier Triumph (<a href='https://seekingalpha.com/symbol/TGI' title='Triumph Group, Inc.'>TGI</a> <font color='green'>+27.4%</font>) skyrockets after crushing <a href=\"https://seekingalpha.com/news/3269480-triumph-beats-1_69-misses-revenue\" target=\"_blank\">FQ4 earnings</a> estimates and announcing a <a href=\"https://seekingalpha.com/pr/16842285-triumph-aerostructures-llc-reaches-comprehensive-settlement-bombardier\" target=\"_blank\">settlement</a> with Bombardier (<a href='https://seekingalpha.com/symbol/BDRAF' title='Bombardier Inc.A'>OTCQX:BDRAF</a>, <a href='https://seekingalpha.com/symbol/BDRBF' title='Bombardier Inc.B'>OTCQX:BDRBF</a>).</li><li>TGI's quarterly earnings more than doubled analyst consensus expectations, although FY 2018 revenue guidance of $3.1B-$3.2B came in below $3.46B analyst consensus estimate.</li><li>TGI says it will \"demonstrate follow-through on our comprehensive efforts [in FY 2017] to streamline our structure, reduce costs, resolve contract issues  and grow our backlog\" in FY 2018.</li>     <li>The settlement involves the design, manufacture and supply of wing components for Bombardier&rsquo;s Global 7000 business aircraft; terms are not disclosed.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269644\" data-linked=\"Triumph +27% on strong earnings, Bombardier settlement\" data-tweet=\"$TGI $TGI $BDRAF - Triumph +27% on strong earnings, Bombardier settlement https://seekingalpha.com/news/3269644-triumphplus-27-on-strong-earnings-bombardier-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3269644-triumphplus-27-on-strong-earnings-bombardier-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269638\" data-ts=\"1495644748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269638-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/TGI' title='Triumph Group, Inc.'>TGI</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure'>NVCR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SBPH' title='Spring Bank Pharmaceuticals'>SBPH</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/RADA' title='Rada Electronics Industries Limited'>RADA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/OOMA' title='Ooma'>OOMA</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/DY' title='Dycom Industries Inc.'>DY</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a> <font color='red'>-12%</font>. SONS <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MDVX' title='Medovex Inc.'>OTC:MDVX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269638\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$TRNX $TCS $TGI - Midday Gainers / Losers https://seekingalpha.com/news/3269638-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3269638-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269636\" data-ts=\"1495643986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMO\" target=\"_blank\">IMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269636-imperial-oil-downgraded-cibc-on-kearl-disappointment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperial Oil downgraded at CIBC on Kearl disappointment</a></h4><ul>     <li>Imperial Oil (<a href='https://seekingalpha.com/symbol/IMO' title='Imperial Oil Ltd'>IMO</a> <font color='red'>-1.6%</font>) is lower after CIBC <a href=\"http://business.financialpost.com/investing/trading-desk/imperial-oil-ltd-downgraded-despite-possible-share-buyback\" target=\"_blank\">downgrades</a> shares to Neutral from Outperform with a $45 price target, trimmed from $50, citing a disappointing performance at the Kearl oil sands project and potential challenges in the Alberta diesel market.</li>     <li>CIBC says IMOs valuation \"has an inherent level of &lsquo;trust us&rsquo; in it, and we worry that the weaker than expected performance at Kearl and poor communication around Cold Lake performance could tarnish the premium,\"&nbsp;CIBC says.</li>     <li>Despite the possibility of a large share buyback - likely starting later this year - lower expectations from Kearl and the Cold Lake heavy oil project suggest IMO&rsquo;s all-in adjusted growth won&rsquo;t &ldquo;stack up to its peers,\" the firm says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269636\" data-linked=\"Imperial Oil downgraded at CIBC on Kearl disappointment\" data-tweet=\"$IMO - Imperial Oil downgraded at CIBC on Kearl disappointment https://seekingalpha.com/news/3269636-imperial-oil-downgraded-cibc-on-kearl-disappointment?source=tweet\" data-url=\"https://seekingalpha.com/news/3269636-imperial-oil-downgraded-cibc-on-kearl-disappointment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269627\" data-ts=\"1495641650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269627-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+7%</font>. FHCO <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/UVV' title='Universal Corporation'>UVV</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269627\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SORL $VERU $WKHS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3269627-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3269627-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269623\" data-ts=\"1495640619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABGLF\" target=\"_blank\">ABGLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269623-acacia-miningminus-30-tanzania-president-fires-mining-minister\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acacia Mining -30% as Tanzania president fires mining minister</a></h4><ul>     <li>Acacia Mining (<a href='https://seekingalpha.com/symbol/ABGLF' title='Acacia Mining PLC'>OTCPK:ABGLF</a>, <a href='https://seekingalpha.com/symbol/ABGLY' title='Acacia Mining PLC ADR'>OTC:ABGLY</a>) <font color='red'>-30%</font> in London trading for its biggest ever one-day loss after Tanzania's president <a href=\"http://www.reuters.com/article/us-tanzania-mining-idUSKBN18K19F\" target=\"_blank\">fires his mining minister</a> following an investigation into possible undeclared exports by mining companies to evade tax.</li>     <li>Pres. Magufuli says the investigation shows that Acacia declared the presence of gold, copper and silver in its mineral sand exports but did not declare other precious metals in the consignments.</li>     <li>The report says Acacia declared ~1.1 metric tons of gold but an analysis established that the shipment contained up to 15 tons; Acacia denies any wrongdoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269623\" data-linked=\"Acacia Mining -30% as Tanzania president fires mining minister\" data-tweet=\"$ABGLF $ABGLF $ABGLY - Acacia Mining -30% as Tanzania president fires mining minister https://seekingalpha.com/news/3269623-acacia-miningminus-30-tanzania-president-fires-mining-minister?source=tweet\" data-url=\"https://seekingalpha.com/news/3269623-acacia-miningminus-30-tanzania-president-fires-mining-minister\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269622\" data-ts=\"1495640155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269622-trading-in-puma-bio-halted-pending-ad-comm-vote-on-neratinib\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Puma Bio halted pending Ad Comm vote on neratinib</a></h4><ul><li>Nasdaq has suspended trading in Puma Biotechnology (<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) until the Ad Comm vote is in, which is happening now.</li><li>The vote was 12 - 4 in favor of the neratinib's benefit/risk profile.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269622\" data-linked=\"Trading in Puma Bio halted pending Ad Comm vote on neratinib\" data-tweet=\"$PBYI - Trading in Puma Bio halted pending Ad Comm vote on neratinib https://seekingalpha.com/news/3269622-trading-in-puma-bio-halted-pending-ad-comm-vote-on-neratinib?source=tweet\" data-url=\"https://seekingalpha.com/news/3269622-trading-in-puma-bio-halted-pending-ad-comm-vote-on-neratinib\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269619\" data-ts=\"1495639510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNKL\" target=\"_blank\">BNKL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269619-bionik-forms-jv-to-bring-robotic-systems-china-shares-up-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bionik forms JV to bring robotic systems into China; shares up 11%</a></h4><ul><li>Bionik Laboratories (<a href='https://seekingalpha.com/symbol/BNKL' title='Bionik Laboratories Corp.'>OTCQB:BNKL</a> <font color='green'>+11.4%</font>) and institutional investor Ginger Capital Investment Holding Ltd. have formed a <a href=\"https://seekingalpha.com/pr/16842437-chinese-fund-invests-bionik-laboratories-establishes-joint-venture\" target=\"_blank\">joint venture</a> &#40;JV&#41; to bring the company's robotic systems into the Chinese market.</li><li>Under the terms of the partnership, Ginger will invest $500K directly into Bionik and $1.45M to fund the JV's operations in China.</li><li>The JV will include an exclusive license to sell Bionik's robotic systems, including InMotion ARM, InMotion HAND and InMotion WRIST, in the country.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269619\" data-linked=\"Bionik forms JV to bring robotic systems into China; shares up 11%\" data-tweet=\"$BNKL - Bionik forms JV to bring robotic systems into China; shares up 11% https://seekingalpha.com/news/3269619-bionik-forms-jv-to-bring-robotic-systems-china-shares-up-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3269619-bionik-forms-jv-to-bring-robotic-systems-china-shares-up-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269615\" data-ts=\"1495638366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCY\" target=\"_blank\">ONCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269615-oncolytics-bio-prices-equity-offering-shares-down-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oncolytics Bio prices equity offering; shares down 19%</a></h4><ul><li>Oncolytics Biotech (ONCYF <font color='red'>-18.8%</font>) <a href=\"https://seekingalpha.com/pr/16843006-oncolytics-biotech-prices-public-offering-units\" target=\"_blank\">prices </a>its public offering of 14.3M Units at $0.70 per Unit for gross proceeds of $10.01M.</li><li>Each Unit consists of one common share and one five-year warrant to purchase one common share at $0.95.</li><li>Closing date is June 1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269615\" data-linked=\"Oncolytics Bio prices equity offering; shares down 19%\" data-tweet=\"$ONCY - Oncolytics Bio prices equity offering; shares down 19% https://seekingalpha.com/news/3269615-oncolytics-bio-prices-equity-offering-shares-down-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3269615-oncolytics-bio-prices-equity-offering-shares-down-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269590\" data-ts=\"1495638068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269590-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/SBPH' title='Spring Bank Pharmaceuticals'>SBPH</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure'>NVCR</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MDVX' title='Medovex Inc.'>OTC:MDVX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269590\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$INO $SBPH $NVCR - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3269590-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3269590-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269608\" data-ts=\"1495637170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNAGF\" target=\"_blank\">LNAGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269608-linde-confirms-merger-agreement-in-principle-praxair\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linde confirms merger agreement in principle with Praxair</a></h4><ul>     <li>Linde (<a href='https://seekingalpha.com/symbol/LNAGF' title='Linde AG'>OTCPK:LNAGF</a>, LNEGY) confirms an agreement in principle with Praxair (<a href='https://seekingalpha.com/symbol/PX' title='Praxair, Inc.'>PX</a> <font color='green'>+2.4%</font>) on a <a href=\"http://www.reuters.com/article/us-linde-m-a-praxair-vote-idUSKBN18K184\" target=\"_blank\">merger of equals</a>.</li>     <li>Linde says the business combination agreement still needs the approval of the PX board as well as Linde's management and executive boards.</li>     <li>The German weekly <em>WirtschaftsWoche</em> earlier today cited sources as saying Linde's supervisory board would vote on the merger agreement next week.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269608\" data-linked=\"Linde confirms merger agreement in principle with Praxair\" data-tweet=\"$LNAGF $LNAGF $LIN - Linde confirms merger agreement in principle with Praxair https://seekingalpha.com/news/3269608-linde-confirms-merger-agreement-in-principle-praxair?source=tweet\" data-url=\"https://seekingalpha.com/news/3269608-linde-confirms-merger-agreement-in-principle-praxair\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269606\" data-ts=\"1495636828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCRX\" target=\"_blank\">PCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269606-pacira-chief-bids-adieu-shares-ease-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacira chief bids adieu; shares ease 2%</a></h4><ul><li>Pacira Pharmaceuticals (<a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-2.2%</font>) President James Scibetta <a href=\"https://seekingalpha.com/pr/16842042-pacira-pharmaceuticals-announces-resignation-james-scibetta\" target=\"_blank\">plans to resign</a> effective June 30 to become CEO at an unnamed early-stage oncology company.</li><li>The company says it will allocate his responsibilities to the current executive team and does not intend to name a successor.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269606\" data-linked=\"Pacira chief bids adieu; shares ease 2%\" data-tweet=\"$PCRX - Pacira chief bids adieu; shares ease 2% https://seekingalpha.com/news/3269606-pacira-chief-bids-adieu-shares-ease-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3269606-pacira-chief-bids-adieu-shares-ease-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269605\" data-ts=\"1495636792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269605-bristow-plunges-after-fq4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow plunges after FQ4 results</a></h4><ul><li>Bristow Group (<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a> <font color='red'>-31%</font>) <font color='red'>loses almost a third of its value</font> after a massive net loss in its fiscal fourth quarter.</li><li>\"We expect fiscal year 2018 results to be impacted by the continued offshore oil and gas industry downturn,\" the company <a href=\"https://seekingalpha.com/pr/16842065-bristow-group-reports-fiscal-fourth-quarter-full-fiscal-year-2017-results\" target=\"_blank\">said</a> in a statement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269605\" data-linked=\"Bristow plunges after FQ4 results\" data-tweet=\"$BRS - Bristow plunges after FQ4 results https://seekingalpha.com/news/3269605-bristow-plunges-after-fq4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3269605-bristow-plunges-after-fq4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269603\" data-ts=\"1495636260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269603-crude-futures-rise-post-inventory-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude futures rise post inventory data</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>-4.4M</strong> barrels vs. -2.4M consensus, -1.8M last week.</li><li>Gasoline <strong>-0.8M</strong> barrels vs. -1.2M consensus, -0.4M last week.</li><li>Distillates <strong>-0.5M </strong>vs. -0.7M consensus, -1.9M last week.</li><li>Futures&nbsp;<font color='green'>+0.08%</font>&nbsp;to $51.5.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3269603\" data-linked=\"Crude futures rise post inventory data\" data-tweet=\"$USO $OIL $UCO - Crude futures rise post inventory data https://seekingalpha.com/news/3269603-crude-futures-rise-post-inventory-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3269603-crude-futures-rise-post-inventory-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269602\" data-ts=\"1495636214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNGA\" target=\"_blank\">MNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269602-magnegas-soars-on-feedstock-improvements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MagneGas soars on feedstock improvements</a></h4><ul><li>MagneGas (<a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='green'>+10.2%</font>) has <a href=\"https://seekingalpha.com/pr/16842817-magnegas-announces-new-feedstock-improvements-resulting-approximately-60-percent-production\" target=\"_blank\">transitioned</a> to a new renewable feedstock that results in approximately a 60% increase in fuel output per minute while yielding approximately a 49% reduction in fuel production cost.</li><li>The company has a patent pending for the usage of the new feedstock in its gasification systems, which it expects will be granted.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269602\" data-linked=\"MagneGas soars on feedstock improvements\" data-tweet=\"$MNGA $TRNX - MagneGas soars on feedstock improvements https://seekingalpha.com/news/3269602-magnegas-soars-on-feedstock-improvements?source=tweet\" data-url=\"https://seekingalpha.com/news/3269602-magnegas-soars-on-feedstock-improvements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269579\" data-ts=\"1495635932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CY\" target=\"_blank\">CY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269579-cypress-semiplus-3-baml-buys-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cypress Semi +3% as BAML buys the dip</a></h4><ul><li>Bank of America Merrill Lynch lists Cypress Semiconductors (<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a> <font color='green'>+3.1%</font>) as a top small- and mid-cap buy opportunity after its recent pullback.</li><li>Analyst Vivek Arya wrote a note listing the reasons to buy, which include diversified growth across multiple markets and a potential EPS doubling within two years due to gross margin expansion.</li><li>Arya also noted that Cypress, a leader in next-gen USB standards, has improved execution and free cash flow generation. The company may have won some designs for the upcoming iPhone 8.</li><li>Reiterates Buy with $18 price target, suggesting nearly&nbsp;<font color='green'>40% upside</font>.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3269579\" data-linked=\"Cypress Semi +3% as BAML buys the dip\" data-tweet=\"$CY - Cypress Semi +3% as BAML buys the dip https://seekingalpha.com/news/3269579-cypress-semiplus-3-baml-buys-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3269579-cypress-semiplus-3-baml-buys-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269600\" data-ts=\"1495635854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLYS\" target=\"_blank\">TLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269600-tillys-pops-after-showing-sales-momentum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilly&#39;s pops after showing sales momentum</a></h4><ul> <li>Tilly's (<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='green'>+14.6%</font>) rallies after posting positive comparable sales growth of 0.6% in Q1 off of late quarter strength.</li> <li>\"We believe our initiatives are gaining traction. After a tough February, our combined March/April comparable store sales were up 5.3%, resulting in a positive comparable store sales result for the first quarter as a whole and our fourth consecutive quarter of year-over-year operating income improvement,\" says CEO Ed Thomas.</li> <li>Tilly's expects Q2 EPS of $0.03 to $0.07 vs. $0.02 consensus.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3269600\" data-linked=\"Tilly&#39;s pops after showing sales momentum\" data-tweet=\"$TLYS - Tilly&#39;s pops after showing sales momentum https://seekingalpha.com/news/3269600-tillys-pops-after-showing-sales-momentum?source=tweet\" data-url=\"https://seekingalpha.com/news/3269600-tillys-pops-after-showing-sales-momentum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269599\" data-ts=\"1495635648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIG\" target=\"_blank\">SIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269599-signet-jewelers-follows-tiffany-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Signet Jewelers follows Tiffany lower</a></h4><ul> <li>Signet Jewelers (<a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a> <font color='red'>-8.5%</font>) is sharply lower after <a href=\"https://seekingalpha.com/news/3269497-tiffanys-q1\" target=\"_blank\">disappointing results</a> from Tiffany rattled the jewelry sector.</li> <li>The stock was also cut to a Neutral rating by Buckingham Research from Buy. A <a href=\"https://twitter.com/BuckResearch/status/867334907676282880\" target=\"_blank\">tweet</a> from the investment firm indicates that it is moving to the sidelines on Signet due to \"soft sales trends and limited visibility to inflection.\"</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3269599\" data-linked=\"Signet Jewelers follows Tiffany lower\" data-tweet=\"$SIG - Signet Jewelers follows Tiffany lower https://seekingalpha.com/news/3269599-signet-jewelers-follows-tiffany-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3269599-signet-jewelers-follows-tiffany-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269591\" data-ts=\"1495634327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269591-linn-energy-to-sell-part-of-california-assets-for-263m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linn Energy to sell part of California assets for $263M</a></h4><ul>     <li>Linn Energy (LNGG <font color='green'>+2.3%</font>) <a href=\"https://seekingalpha.com/pr/16842166-linn-energy-announces-sale-portion-california-assets-263-million\" target=\"_blank\">agrees to sell</a> its properties in California's San Joaquin Basin to an undisclosed buyer for $263M.</li>     <li>The deal is Linn's <a href=\"http://www.bizjournals.com/houston/news/2017/05/23/linn-energy-to-sell-more-assets-first-deal-in.html\" target=\"_blank\">second since emerging from bankruptcy</a> in February and the first that is part of the company's previously announced non-core divestiture program.</li>     <li>The San Joaquin Basin properties consist of ~500 total net acres which produced 3K boe/day during Q1; Linn had planned to spend $21M to develop the properties during H2 but will now focus on other projects or pay down debt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269591\" data-linked=\"Linn Energy to sell part of California assets for $263M\" data-tweet=\"$ROAN - Linn Energy to sell part of California assets for $263M https://seekingalpha.com/news/3269591-linn-energy-to-sell-part-of-california-assets-for-263m?source=tweet\" data-url=\"https://seekingalpha.com/news/3269591-linn-energy-to-sell-part-of-california-assets-for-263m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269589\" data-ts=\"1495633761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTEC\" target=\"_blank\">NTEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269589-intec-nabs-new-u-s-patent-protecting-accordion-pill-technology-shares-ahead-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intec nabs new U.S. patent protecting Accordion Pill technology; shares ahead 4%</a></h4><ul><li>Intec Pharma Ltd. (<a href='https://seekingalpha.com/symbol/NTEC' title='Intec Pharma'>NTEC</a> <font color='green'>+3.7%</font>) is up in early trading on the <a href=\"https://seekingalpha.com/filing/3565124\" target=\"_blank\">news </a>that the USPTO has issued Patent No. 9,655,859 covering its Accordion Pill platform technology. The patent, \"Accordion Pill Comprising Levodopa for Improved Treatment of Parkinson's Diseases Symptoms\" will be in effect until November 2031.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269589\" data-linked=\"Intec nabs new U.S. patent protecting Accordion Pill technology; shares ahead 4%\" data-tweet=\"$NTEC - Intec nabs new U.S. patent protecting Accordion Pill technology; shares ahead 4% https://seekingalpha.com/news/3269589-intec-nabs-new-u-s-patent-protecting-accordion-pill-technology-shares-ahead-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3269589-intec-nabs-new-u-s-patent-protecting-accordion-pill-technology-shares-ahead-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269585\" data-ts=\"1495632980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROW\" target=\"_blank\">TROW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269585-t-rowe-price-down-2_5-early-after-two-notch-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T. Rowe Price down 2.5% early after two-notch downgrade</a></h4><ul><li>\"Squeezed at both ends,\" is how UBS analyst Brennan Hawken describes the outlook for T. Rowe Price (<a href='https://seekingalpha.com/symbol/TROW' title='T. Rowe Price Group, Inc.'>TROW</a> <font color='red'>-2.5%</font>) as he downgrades to Sell from Buy. He cuts his price target to a Street-low $61, suggesting more than&nbsp;<font color='red'>10% downside&nbsp;</font>from yesterday's close.</li><li>While a lot of focus is on the DOL's fiduciary rule - and that's certainly going to hurt - less noticed is the 2010 DOL rule boosting transparency into 401k fees - with plaintiffs lawyers widening their targets to include the smaller plans at the core of T. Rowe Price's retirement business.</li><li>Then there's the cost side, and expense headwinds are \"unavoidable just to tread water,\" says Hawken.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3269585\" data-linked=\"T. Rowe Price down 2.5% early after two-notch downgrade\" data-tweet=\"$TROW - T. Rowe Price down 2.5% early after two-notch downgrade https://seekingalpha.com/news/3269585-t-rowe-price-down-2_5-early-after-two-notch-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3269585-t-rowe-price-down-2_5-early-after-two-notch-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269581\" data-ts=\"1495632494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OOMA\" target=\"_blank\">OOMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269581-oomaminus-28_6-q1-results-guidance-spur-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ooma -28.6% as Q1 results, guidance spur downgrades</a></h4><ul>   <li>Ooma (NYSE:<a href='https://seekingalpha.com/symbol/OOMA' title='Ooma'>OOMA</a>) is <font color='red'>off 28.6%</font> premarket, after a <a href=\"https://seekingalpha.com/news/3269420-ooma-minus-12_8-percent-postmarket-q1-revenues-miss\" target=\"_blank\">miss on revenues in Q1</a> and some downbeat revenue guidance for the quarters ahead has prompted analyst downgrades.</li>    <li>William Blair cut the stock to Market Perform off the results. Credit Suisse has gone to Neutral as well, with a price target of $12; Ooma closed at $11.70 yesterday and is indicated at $8.36 in premarket quotes.</li>    <li>Meanwhile, BofA Merrill Lynch has cut the stock to Underperform with a $10 price target, implying 15% downside from yesterday's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269581\" data-linked=\"Ooma -28.6% as Q1 results, guidance spur downgrades\" data-tweet=\"$OOMA - Ooma -28.6% as Q1 results, guidance spur downgrades https://seekingalpha.com/news/3269581-oomaminus-28_6-q1-results-guidance-spur-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3269581-oomaminus-28_6-q1-results-guidance-spur-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269577\" data-ts=\"1495632233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269577-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+40%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16842550-inovio-hiv-vaccine-elicits-nearly-100-percent-immune-response-rates-clinical-study\" target=\"_blank\">announcing</a> that its HIV vaccine, PENNVAX<sup>&reg;</sup>-GP, produced nearly 100% response rates in a clinical study.</li><li><a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a> <font color='green'>+35%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3269395-container-store-beats-0_08-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='green'>+20%</font>.</li><li><a href='https://seekingalpha.com/symbol/RADA' title='Rada Electronics Industries Limited'>RADA</a> <font color='green'>+12%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3269549-rada-electronics-reports-q1-results\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/TGI' title='Triumph Group, Inc.'>TGI</a> <font color='green'>+11%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3269480-triumph-beats-1_69-misses-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a> <font color='green'>+10%</font>.</li><li><a href='https://seekingalpha.com/symbol/INTU' title='Intuit Inc.'>INTU</a> <font color='green'>+8%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3269388-intuit-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li><li>FGL <font color='green'>+6%</font>&nbsp;on being acquired by CF Corp.</li><li><a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+5%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16842347-insys-therapeutics-inc-announces-fda-final-product-label-syndros\" target=\"_blank\">announcing</a> that FDA has approved the final product label for Syndros oral solution.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269577\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$INO $TCS $TLYS - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3269577-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3269577-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269575\" data-ts=\"1495631960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269575-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a>&nbsp;<font color='red'>-28%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3269406-aegean-marine-petroleum-network-eps-0_03\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3269515-chicos-fas-misses-0_03-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/DY' title='Dycom Industries Inc.'>DY</a>&nbsp;<font color='red'>-14%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3269538-dycom-13-percent-soft-guidance\" target=\"_blank\">lower guidance</a>.</li><li><a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3269492-tiffany-beats-0_04-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3269547-bunge-says-talks-glencore-minus-7-percent-premarket\" target=\"_blank\">announcing</a> its denial of business with Glencore.</li><li><a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3269397-neurocrines-ingrezza-flunks-mid-stage-study-tourettes-shares-8-percent-hours\" target=\"_blank\">announcing</a> results of Ingrezza study.</li><li><a href='https://seekingalpha.com/symbol/AAP' title='Advance Auto Parts, Inc.'>AAP</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3269487-advance-auto-parts-misses-0_58-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3269575\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$ANW $CHS $DY - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3269575-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3269575-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269574\" data-ts=\"1495631919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANW\" target=\"_blank\">ANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269574-aegean-marineminus-29-on-one-of-worst-quarters-in-companys-history\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegean Marine -29% on &quot;one of the worst quarters in the company&#39;s history&quot;</a></h4><ul><li>Aegean Marine Petroleum (<a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a>) <font color='red'>-29%</font> premarket after posting a wide <a href=\"https://seekingalpha.com/news/3269406-aegean-marine-petroleum-network-eps-0_03\" target=\"_blank\">Q1 earnings</a> miss, which Stifel analysts call \"one of the worst quarters in the company's history\" after the company had given a strong endorsement of its business conditions in March.</li><li>In <a href=\"https://www.streetinsider.com/Analyst+Comments/Stifel+Downgrades+Aegean+Marine+Petroleum+Network+%28ANW%29+to+Hold/12939415.html\" target=\"_blank\">downgrading</a> shares to Hold from Buy with a $9 price target, chopped in half from $18, Stifel cites increasing competition in several of ANW's markets which impacted  Q1 margins and overall profitability, although volumes were higher than  expected and up Y/Y; Q1 costs were higher than expected in  almost every category despite the company's focus on cost cutting.</li><li>Stifel says it will remain on the sidelines until management is able to right the ship or the stock's valuation becomes  overwhelmingly compelling.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269574\" data-linked=\"Aegean Marine -29% on &quot;one of the worst quarters in the company&#39;s history&quot;\" data-tweet=\"$ANW - Aegean Marine -29% on &quot;one of the worst quarters in the company&#39;s history&quot; https://seekingalpha.com/news/3269574-aegean-marineminus-29-on-one-of-worst-quarters-in-companys-history?source=tweet\" data-url=\"https://seekingalpha.com/news/3269574-aegean-marineminus-29-on-one-of-worst-quarters-in-companys-history\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269573\" data-ts=\"1495631278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269573-inovios-hiv-vaccine-elicits-almost-complete-immune-response-rates-in-nih-study-shares-up-36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio&#39;s HIV vaccine elicits almost complete immune response rates in NIH study; shares up 36% premarket</a></h4><ul><li>Micro cap Inovio Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) rockets&nbsp;<font color='green'>36%&nbsp;</font>premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16842550-inovio-hiv-vaccine-elicits-nearly-100-percent-immune-response-rates-clinical-study\" target=\"_blank\">announcement </a>of study results that demonstrated almost 100% immune response rates by HIV vaccine candidate PENNVAX-GP.</li><li>The study was supported by NIH's National Institute of Allergy and Infectious Diseases and by the HIV Vaccine Trials Network, in collaboration with the company.</li><li>A four-dose regimen of PENNVAX-GP, in combination with a DNA-encoded immune activator, IL-12, administered via intradermal &#40;ID&#41; or intramuscular &#40;IM&#41; injection, produced a cellular immune response to at least one of the vaccine's four antigens in 93% (n=71/76) of evaluable vaccinated participants while 94% (n=62/66) of evaluated participants showed an env-specific antibody response.</li><li>Among participants receiving PENNVAX-GP and IL-12 with ID immunization, 96% (n=27/28) demonstrated a cellular response and 96% (n=27/28) showed an HIV env-specific antibody response.</li><li>In the group receiving the combination via IM vaccination, 100% (n=27/27) showed a cellular response and 90% (n=19/21) showed an env-specific antibody response.</li><li>The company plans to advance PENNVAX-GP into later-stage development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269573\" data-linked=\"Inovio&#39;s HIV vaccine elicits almost complete immune response rates in NIH study; shares up 36% premarket\" data-tweet=\"$INO - Inovio&#39;s HIV vaccine elicits almost complete immune response rates in NIH study; shares up 36% premarket https://seekingalpha.com/news/3269573-inovios-hiv-vaccine-elicits-almost-complete-immune-response-rates-in-nih-study-shares-up-36?source=tweet\" data-url=\"https://seekingalpha.com/news/3269573-inovios-hiv-vaccine-elicits-almost-complete-immune-response-rates-in-nih-study-shares-up-36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269565\" data-ts=\"1495630731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCA\" target=\"_blank\">FCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269565-fiatplus-3-sergio-defends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiat +3% as Sergio defends</a></h4><ul> <li>Shares of Fiat Chrysler Autmobiles (NASDAQ:<a href='https://seekingalpha.com/symbol/FCA' title='First Trust China AlphaDEX ETF'>FCA</a>) are higher in early trading after the company mounted a strong defense following a DOJ lawsuit.</li> <li>Analysts note the long history of Fiat pushing back hard against regulators in enforcemens cases as they predict a long process before a settlement might be struck.</li> <li>Sergio Marchionne found a microphone and told <a href=\"http://www.ansa.it/english/news/general_news/2017/05/23/us-files-suit-for-fca-diesel-emissions-5_afd10cb1-a30e-4fc1-a13e-5f51c30efb35.html\" target=\"_blank\">Italian media</a> that the company would not be \"so stupid\" to use illegal software to cheat on emissions testing.</li> <li>FCAU <font color='green'>+3.29%</font> premarket to $10.66.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269565\" data-linked=\"Fiat +3% as Sergio defends\" data-tweet=\"$FCA - Fiat +3% as Sergio defends https://seekingalpha.com/news/3269565-fiatplus-3-sergio-defends?source=tweet\" data-url=\"https://seekingalpha.com/news/3269565-fiatplus-3-sergio-defends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269564\" data-ts=\"1495630704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FG\" target=\"_blank\">FG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269564-fidelity-guaranty-life-finds-buyer-for-1_8b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fidelity &amp; Guaranty Life finds a buyer for $1.8B</a></h4><ul><li>The buyer is blank check company CF Corp (CFCO), and the all-cash deal works out to $31.10 per Fidelity &amp; Guaranty (FGL) share, an&nbsp;<font color='green'>8.4% premium</font>&nbsp;to last night's close. That's 1.1x Mach 31 adjusted book value.</li><li>Alongside, CF Corp and HRG Group (NYSE:<a href='https://seekingalpha.com/symbol/HRG' title='HRG Group, Inc.'>HRG</a>) - FGL's largest shareholder - have approved a deal under which CF will acquire certain reinsurance companies form HRG.</li><li>The deal is expected to close in Q4.</li><li><a href=\"http://www.cfcorpandfidelity.com/\" target=\"_blank\">Transaction website</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269564\" data-linked=\"Fidelity &amp; Guaranty Life finds a buyer for $1.8B\" data-tweet=\"$FG $FG $HRG - Fidelity &amp; Guaranty Life finds a buyer for $1.8B https://seekingalpha.com/news/3269564-fidelity-guaranty-life-finds-buyer-for-1_8b?source=tweet\" data-url=\"https://seekingalpha.com/news/3269564-fidelity-guaranty-life-finds-buyer-for-1_8b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269562\" data-ts=\"1495630239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOW\" target=\"_blank\">LOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269562-lowes-loses-ground-to-home-depot-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lowe&#39;s loses ground to Home Depot in Q1</a></h4><ul> <li>Lowe's (NYSE:<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a>) falls in early trading after the company falls short of matching the performance of rival Home Depot (NYSE:<a href='https://seekingalpha.com/symbol/HD' title='Home Depot, Inc.'>HD</a>) in <a href=\"https://seekingalpha.com/news/3269485-lowes-lower-earnings-miss\" target=\"_blank\">Q1</a>.</li> <li>Comparable sales at Lowe's increased 1.9% during the quarter vs. +2.6% consensus and +5.5% at Home Depot for a roughly overlapping period. Gross margin also trailed off more year over year for Lowe's than Home Depot.</li> <li>Looking ahead, Lowe's sees FY17 EPS of $4.30 vs. $4.64 consensus.</li> <li>LOW <font color='red'>-2.68%</font> premarket to $80.14. HD&nbsp;<font color='red'>-0.28%</font>&nbsp;to $154.39. Both stocks are up roughly 16% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269562\" data-linked=\"Lowe&#39;s loses ground to Home Depot in Q1\" data-tweet=\"$LOW $LOW $HD - Lowe&#39;s loses ground to Home Depot in Q1 https://seekingalpha.com/news/3269562-lowes-loses-ground-to-home-depot-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3269562-lowes-loses-ground-to-home-depot-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269561\" data-ts=\"1495630114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPHS\" target=\"_blank\">SPHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269561-sophiris-bio-on-go-mid-stage-study-of-topsalysin-in-prostate-cancer-shares-ahead-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sophiris Bio on go with mid-stage study of topsalysin in prostate cancer; shares ahead 9% premarket</a></h4><ul><li>Thinly traded nano cap Sophiris Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16841983-sophiris-bio-provides-update-phase-2b-study-topsalysin-localized-prostate-cancer\" target=\"_blank\">announcement </a>that it has received regulatory clearance for the diluent used to dilute topsalysin (PRX302). Clinical sites can now begin dosing patients in its Phase 2b clinical trial in localized prostate cancer.</li><li><a href=\"http://www.sophirisbio.com/prx-302/\" target=\"_blank\">Topsalysin&nbsp;</a>is a modified recombinant protein engineered to be selectively activated by an enzyme in the prostate. It is administered via direct injection into the prostate gland where it kills cancer cells without damaging surrounding tissue.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3188206-sophiris-bios-lead-product-candidate-shows-encouraging-action-small-mid-stage-prostate-cancer\" target=\"_blank\">Sophiris Bio's lead product candidate shows encouraging action in small mid-stage prostate cancer study; shares up 51% after hours</a> (June 9, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3269561\" data-linked=\"Sophiris Bio on go with mid-stage study of topsalysin in prostate cancer; shares ahead 9% premarket\" data-tweet=\"$SPHS - Sophiris Bio on go with mid-stage study of topsalysin in prostate cancer; shares ahead 9% premarket https://seekingalpha.com/news/3269561-sophiris-bio-on-go-mid-stage-study-of-topsalysin-in-prostate-cancer-shares-ahead-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3269561-sophiris-bio-on-go-mid-stage-study-of-topsalysin-in-prostate-cancer-shares-ahead-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269553\" data-ts=\"1495628898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269553-ja-solarminus-6-q1-gross-margin-falls-cautious-on-h2-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JA Solar -6% as Q1 gross margin falls; cautious on H2 outlook</a></h4><ul>     <li>JA&nbsp;Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a>) <font color='red'>-5.9%</font> premarket despite reporting better than expected <a href=\"https://seekingalpha.com/news/3269504-ja-solar-holdings-beats-0_05-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenues.</li>     <li>JASO says it expects \"solid demand\" from China in Q2 but is cautious on H2's business outlook, \"given limited visibility into customer demand, as  well as the competitive pricing environment across multiple geographies.&rdquo;</li>     <li>JASO says total Q1 shipments were 1,392.7 MW, in line with previously announced guidance; external shipments of 1,375.3 MW rose 32.5% Y/Y but fell 2.6% Q/Q.</li>     <li>Q1 gross margin was 11.7%, vs. 16.6% in the year-ago quarter and 12.9% in Q4 2016, as the average selling price of solar modules fell.</li>     <li>JASO expects total Q2 cell and module shipments of 1,550-1,650 MW.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269553\" data-linked=\"JA Solar -6% as Q1 gross margin falls; cautious on H2 outlook\" data-tweet=\"$JASO - JA Solar -6% as Q1 gross margin falls; cautious on H2 outlook https://seekingalpha.com/news/3269553-ja-solarminus-6-q1-gross-margin-falls-cautious-on-h2-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3269553-ja-solarminus-6-q1-gross-margin-falls-cautious-on-h2-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269551\" data-ts=\"1495628597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269551-alnylam-readies-equity-offering-shares-slip-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam readies equity offering; shares slip 3% premarket</a></h4><ul><li>Alnylam (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>) is down&nbsp;<font color='red'>3%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16841966-alnylam-pharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned public offering</a> of 5M common shares. Price and terms have yet to be announced. Net proceeds will be used for general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269551\" data-linked=\"Alnylam readies equity offering; shares slip 3% premarket\" data-tweet=\"$ALNY - Alnylam readies equity offering; shares slip 3% premarket https://seekingalpha.com/news/3269551-alnylam-readies-equity-offering-shares-slip-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3269551-alnylam-readies-equity-offering-shares-slip-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269549\" data-ts=\"1495628326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RADA\" target=\"_blank\">RADA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269549-rada-electronics-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rada Electronics reports Q1 results</a></h4><ul><li>Rada Electronics (NASDAQ:<a href='https://seekingalpha.com/symbol/RADA' title='Rada Electronics Industries Limited'>RADA</a>): Q1 EPS of $0.02</li><li>Revenue of $4.7M (+88.0% Y/Y)</li><li>Shares <font color='green'>+16.9%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16842600-rada-electronic-industries-announces-q1-2017-results-yoy-revenue-growth-91-percent-return'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269549\" data-linked=\"Rada Electronics reports Q1 results\" data-tweet=\"$RADA - Rada Electronics reports Q1 results https://seekingalpha.com/news/3269549-rada-electronics-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3269549-rada-electronics-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269547\" data-ts=\"1495628206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BG\" target=\"_blank\">BG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269547-bunge-says-not-in-talks-glencoreminus-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bunge says not in talks with Glencore, -7% premarket</a></h4><ul>     <li>Bunge (NYSE:<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a>) <font color='red'>-6.9%</font> premarket after issuing a brief <a href=\"https://seekingalpha.com/pr/16842175-bunge-issues-statement\" target=\"_blank\">denial that it is in business combination discussions</a> with Glencore (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>) or Glencore Agriculture Ltd.</li>     <li>BG's statement would appear to contradict <a href=\"https://seekingalpha.com/news/3269387-glencore-confirms-made-takeover-approach-bunge\" target=\"_blank\">yesterday's statement</a> from Glencore that it had made an \"informal approach\" about a potential combination.</li>     <li>BG surged 16.6% in yesterday's trade following an initial <em>WSJ</em> report, fueling ongoing speculation that the world's top grain traders and food producers are ripe for a wave of consolidation; <a href='https://seekingalpha.com/symbol/ADM' title='Archer Daniels Midland Co.'>ADM</a> closed <font color='green'>+3.7%</font>, <a href='https://seekingalpha.com/symbol/ANDE' title='The Andersons, Inc.'>ANDE</a> <font color='green'>+3.4%</font> yesterday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3269547\" data-linked=\"Bunge says not in talks with Glencore, -7% premarket\" data-tweet=\"$BG $BG $GLCNF - Bunge says not in talks with Glencore, -7% premarket https://seekingalpha.com/news/3269547-bunge-says-not-in-talks-glencoreminus-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3269547-bunge-says-not-in-talks-glencoreminus-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269538\" data-ts=\"1495627300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DY\" target=\"_blank\">DY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269538-dycom-down-13-after-soft-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dycom down 13% after soft guidance</a></h4><ul><li>The company topped FQ3 (ended April 29) estimates, but the FQ4 outlook for adjusted EPS of $1.35-$1.50 is well shy of consensus $1.79. Revenue is seen at $780M-$810M vs. estimates for $848M.</li><li><a href=\"http://www.dycomind.com\" target=\"_blank\">Conference call at 9 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3269481-dycom-industries-beats-0_11-beats-revenue\" target=\"_blank\">Dycom Industries beats by $0.11, beats on revenue</a> (May 24)</li><li><a href='https://seekingalpha.com/symbol/DY' title='Dycom Industries Inc.'>DY</a>&nbsp;<font color='red'>-13%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3269538\" data-linked=\"Dycom down 13% after soft guidance\" data-tweet=\"$DY - Dycom down 13% after soft guidance https://seekingalpha.com/news/3269538-dycom-down-13-after-soft-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3269538-dycom-down-13-after-soft-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269533\" data-ts=\"1495626990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269533-steel-sector-upgraded-credit-suisse-recovery-seen-in-late-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel sector upgraded at Credit Suisse as recovery seen in late Q3</a></h4><ul><li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color='green'>+2.3%</font>, Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>) <font color='green'>+3.3%</font> and Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>) <font color='green'>+4.6%</font> premarket after Credit Suisse upgrades the steel sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a>) to Outperform from Market Weight and raises the three companies to Outperform from Neutral, saying its previously cautious  investment thesis on the sector has played out and prices are likely to recover by  late Q3.</li><li>Recovery in energy and construction markets could increase U.S. hot rolled coil demand  by ~1.2M tons over the next 18 months, the firm says, driving U.S. downstream HRC rolling  utilization rates above the critical level of 85%.</li><li>Credit Suisse says its channel checks with U.S. traders and OEMs indicate that a structural  change is taking place with respect to U.S. trade, both from an importer  and exporter basis, which the market is underestimating.</li><li>The firm also notes the outcome of Section 232  trade action will have very significant consequences for all domestic steel  equities.</li><li>Source:&nbsp;Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3269533\" data-linked=\"Steel sector upgraded at Credit Suisse as recovery seen in late Q3\" data-tweet=\"$X $X $NUE - Steel sector upgraded at Credit Suisse as recovery seen in late Q3 https://seekingalpha.com/news/3269533-steel-sector-upgraded-credit-suisse-recovery-seen-in-late-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3269533-steel-sector-upgraded-credit-suisse-recovery-seen-in-late-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269529\" data-ts=\"1495626664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269529-ad-comm-review-of-pumas-neratinib-getting-started\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad Comm review of Puma&#39;s neratinib getting started</a></h4><ul><li>Investors on both sides of the aisle will be closely following the proceedings in today's FDA advisory committee meeting regarding Puma Biotechnology's (NYSE:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) marketing application seeking approval of neratinib for HER2+ breast cancer.</li><li>TheStreet's Adam Feuerstein is hosting a <a href=\"https://www.thestreet.com/story/14146508/1/puma-bio-fda-advisory-panel-live-blog.html\" target=\"_blank\">live blog</a> on the action.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;premarket, but only on 30 shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3269037-briefing-docs-ad-comm-review-pumas-neratinib-shares-52-percent\" target=\"_blank\">Briefing docs out for Ad Comm review of Puma's neratinib; shares up 52%</a> (May 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3269529\" data-linked=\"Ad Comm review of Puma&#39;s neratinib getting started\" data-tweet=\"$PBYI - Ad Comm review of Puma&#39;s neratinib getting started https://seekingalpha.com/news/3269529-ad-comm-review-of-pumas-neratinib-getting-started?source=tweet\" data-url=\"https://seekingalpha.com/news/3269529-ad-comm-review-of-pumas-neratinib-getting-started\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269519\" data-ts=\"1495625776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269519-seadrillplus-15-on-q1-beat-new-ceo-to-replace-wulff-advanced-debt-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill +15% on Q1 beat, new CEO to replace Wulff, &quot;advanced&quot; debt talks</a></h4><ul>     <li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a>)&nbsp;<font color='green'>+15%</font> premarket after posting better than expected <a href=\"https://seekingalpha.com/news/3269473-seadrill-beats-0_07-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenues, and appointing Anton Dibowitz as its <a href=\"http://www.seadrill.com/investor-relations/news/pr-story.aspx?ResultPageURL=http://cws.huginonline.com/S/135817/PR/201705/2107305.xml\" target=\"_blank\">new CEO</a>, effective July 1.</li>     <li>Dibowitz, currently Chief Commercial Officer and Executive VP, will replace Per Wullf, who will continue as a director.</li>     <li>SDRL says it is in \"advanced discussions\" with lenders and investors on how to restructure its $14B debt ahead of a July 31 deadline, but \"reading between the lines, it looks like most of the work could be completed in the course of June,\" ABG Sundal Collier analyst Lukas Daul tells Reuters. \"The fact that they'll get a new chief executive from July 1 suggests they could <a href=\"http://www.reuters.com/article/us-seadrill-results-idUSKBN18K0VL\" target=\"_blank\">hand him a restructured company</a>.\"</li>     <li>SDRL's Q1 EBITDA totaled $291M, beating analyst expectations for $271M but down from $528M in the year-ago quarter; its current order backlog is $3.4B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269519\" data-linked=\"Seadrill +15% on Q1 beat, new CEO to replace Wulff, &quot;advanced&quot; debt talks\" data-tweet=\"$SDRL - Seadrill +15% on Q1 beat, new CEO to replace Wulff, &quot;advanced&quot; debt talks https://seekingalpha.com/news/3269519-seadrillplus-15-on-q1-beat-new-ceo-to-replace-wulff-advanced-debt-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3269519-seadrillplus-15-on-q1-beat-new-ceo-to-replace-wulff-advanced-debt-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269497\" data-ts=\"1495623194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIF\" target=\"_blank\">TIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269497-on-tiffanys-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Tiffany&#39;s Q1</a></h4><ul><li>Tiffany (NYSE:<a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a>) reports comparable-store sales declined 3% in <a href=\"https://seekingalpha.com/pr/16842336-tiffany-reports-first-quarter-results\" target=\"_blank\">Q1</a>.</li><li>Geographic revenue: Americas: $392M (-3%); Asia-Pacific: $257M (+8%); Japan: $128M (-2%); Europe: $94M (-3%); Other: $28M (+32%).</li><li>Gross margin rate improved 80 bps to 62% favorable product input costs and a shift in sales mix toward higher margin fashion jewelry products.</li><li>SG&amp;A expense rate up 30 bps to 45.8%.</li><li>Operating margin grew 110 bps to 16.2%.</li><li>Inventory &nbsp;fell 5.3% Y/Y to $2.2B.</li><li>Store count +2 Y/Y to 310.</li><li><b>FY2017 Guidance</b>:&nbsp;Net sales:&nbsp;increase by a low single-digit percentage; Diluted EPS:&nbsp;increase by a high-single-digit percentage; Free cash flow: at least $450M; Capex: $250M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269497\" data-linked=\"More on Tiffany&#39;s Q1\" data-tweet=\"$TIF - More on Tiffany&#39;s Q1 https://seekingalpha.com/news/3269497-on-tiffanys-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3269497-on-tiffanys-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269490\" data-ts=\"1495622424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAP\" target=\"_blank\">AAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269490-on-advance-auto-parts-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Advance Auto Parts&#39; Q1</a></h4><ul>     <li>Advance Auto Parts (NYSE:<a href='https://seekingalpha.com/symbol/AAP' title='Advance Auto Parts, Inc.'>AAP</a>) reports comparable-store sales declined 2.7% in <a href=\"https://seekingalpha.com/pr/16842329-advance-auto-parts-reports-first-quarter-fiscal-2017-results\" target=\"_blank\">Q1</a>.</li>     <li>Gross margin rate slipped 135 bps to 44% due to investments in the customer, inventory optimization efforts and supply chain expense deleverage due to the comparable store sales decline.</li>     <li>Adjusted SG&amp;A expense rate up 220 bps to 36.9%.</li>     <li>Adjusted&nbsp;operating margin rate squeezed 350 bps to 7.1%.</li>     <li>Store count -3 Q/Q to 5,059.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3269490\" data-linked=\"More on Advance Auto Parts&#39; Q1\" data-tweet=\"$AAP - More on Advance Auto Parts&#39; Q1 https://seekingalpha.com/news/3269490-on-advance-auto-parts-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3269490-on-advance-auto-parts-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269485\" data-ts=\"1495621042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOW\" target=\"_blank\">LOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269485-lowes-lower-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lowe&#39;s lower on earnings miss</a></h4><ul><li>Lowe's (NYSE:<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a>) reports comparable-store sales rose 1.9% in <a href=\"https://seekingalpha.com/pr/16842311-lowes-reports-first-quarter-sales-earnings-results\" target=\"_blank\">Q1</a>.</li><li>Comps for the U.S.&nbsp;home improvement&nbsp;business increased 2% for the quarter.</li><li>Gross margin rate slipped 64 bps to 34.4%.</li><li>SG&amp;A expense rate grew 73 bps to 22.99%.</li><li>Operating margin rate dropped 117 bps to 9.25%.</li><li>Merchandise inventory +10.8% to $12.25B.</li><li>Home improvement and hardware stores +277 Y/Y to 2,137.</li><li><b>FY2017 Guidance</b>: Sales growth: ~+5%;&nbsp;Comparable-store sales: ~+3.5%; Operating margin: ~+120 bps; Tax rate: ~37.8%; Diluted&nbsp;EPS: ~$4.30; New stores: ~35.</li><li>LOW&nbsp;<font color='red'>-7.34%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3269485\" data-linked=\"Lowe&#39;s lower on earnings miss\" data-tweet=\"$LOW - Lowe&#39;s lower on earnings miss https://seekingalpha.com/news/3269485-lowes-lower-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3269485-lowes-lower-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3269473\" data-ts=\"1495618445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3269473-seadrill-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill beats by $0.07, beats on revenue</a></h4><ul><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a>): Q1 EPS of $0.06 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $569M (-36.1% Y/Y) <font color='green'>beats by $22.84M</font>.</li><li>Shares <font color='green'>+12%</font> PM.</li><li><a href='http://www.seadrill.com/investor-relations/news/pr-story.aspx?ResultPageURL=http://cws.huginonline.com/S/135817/PR/201705/2107304.xml'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3269473\" data-linked=\"Seadrill beats by $0.07, beats on revenue\" data-tweet=\"$SDRL - Seadrill beats by $0.07, beats on revenue https://seekingalpha.com/news/3269473-seadrill-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3269473-seadrill-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":69,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}